1. Home
  2. ZYME vs LCID Comparison

ZYME vs LCID Comparison

Compare ZYME & LCID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$22.81

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

HOLD

Current Price

$6.30

Market Cap

2.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
LCID
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
ZYME
LCID
Price
$22.81
$6.30
Analyst Decision
Strong Buy
Hold
Analyst Count
11
7
Target Price
$38.90
$15.71
AVG Volume (30 Days)
531.8K
25.5M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
$105,965,000.00
$595,271,000.00
Revenue This Year
$183.10
$71.67
Revenue Next Year
N/A
$89.72
P/E Ratio
N/A
N/A
Revenue Growth
38.87
N/A
52 Week Low
$11.86
$1.97
52 Week High
$29.75
$25.22

Technical Indicators

Market Signals
Indicator
ZYME
LCID
Relative Strength Index (RSI) 36.89 50.83
Support Level $22.20 $5.59
Resistance Level $23.66 $6.85
Average True Range (ATR) 0.92 0.90
MACD -0.30 0.06
Stochastic Oscillator 1.07 72.09

Price Performance

Historical Comparison
ZYME
LCID

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design, which led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

Share on Social Networks: